IHS Chemical Week

Regions :: China

Orchid exits API jv in China

10:47 AM MST | November 12, 2012 | Deepti Ramesh

Orchid Chemicals & Pharmaceuticals (Chennai, India), a leading Indian pharmaceutical company, says it is exiting its 50-50 active pharmaceutical ingredient (API) manufacturing joint venture in China with North China Pharmaceutical Corp. (NCPC; Shijiazhuang, China), NCPC-Orchid Pharmaceuticals (Shijiazhuang). Orchid’s 50% stake in the jv will be transferred to NCPC for a total cash consideration of $13.9 million, Orchid says. Orchid and NCPC formed the jv in 2002 to establish a cephalosporin API manufacturing facility at Shijiazhuang. “With...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa